Temat: "Anti-HIV Agents" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: HIV protease resistance mutations in patients receiving second-line antiretroviral therapy in Libreville, Gabon.
Autorzy:: Nzengui-Nzengui GF; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon.
Mourembou G; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon.
M'boyis-Kamdem H; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon.
Kombila-Koumavor AC; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon.
Ndjoyi-Mbiguino A; Département de Bactériologie- Virologie, Laboratoire National de Référence IST/VIH/Sida, Université des Sciences de la Santé, Libreville, Gabon. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Mar 14; Vol. 24 (1), pp. 316. Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:: Journal Article
MeSH Terms:: Anti-HIV Agents*/therapeutic use
Anti-HIV Agents*/pharmacology
HIV Infections*/drug therapy
HIV-1*/genetics
Male ; Humans ; Female ; Reverse Transcriptase Inhibitors/therapeutic use ; HIV Protease/genetics ; Gabon ; Anti-Retroviral Agents/therapeutic use ; Protease Inhibitors/therapeutic use ; Mutation ; Drug Resistance, Viral/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 2.

Tytuł:: Analysis of ART effects and drug resistance in adult HIV/AIDS patients in Meigu County, Liangshan Prefecture, China.
Autorzy:: Yuan L; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Chen K; Meigu County People's Hospital, Meigu, Liangshan Prefecture, Sichuan, China.
Cai Y; Meigu County People's Hospital, Meigu, Liangshan Prefecture, Sichuan, China.
Zhou Z; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Yang J; Meigu County People's Hospital, Meigu, Liangshan Prefecture, Sichuan, China.
Jiqu W; Meigu County People's Hospital, Meigu, Liangshan Prefecture, Sichuan, China.
Zhu Q; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Zhang H; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Niu S; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Sun H; Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Feb 01; Vol. 24 (1), pp. 155. Date of Electronic Publication: 2024 Feb 01.
Typ publikacji:: Journal Article
MeSH Terms:: Acquired Immunodeficiency Syndrome*/drug therapy
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
HIV-1*/genetics
Nucleic Acids*
Adult ; Humans ; Emtricitabine/therapeutic use ; Nevirapine/pharmacology ; Nevirapine/therapeutic use ; Didanosine ; Mutation ; Drug Resistance ; Drug Resistance, Viral/genetics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: HIV viral suppression and risk of viral rebound in patients on antiretroviral therapy: a two- year retrospective cohort study in Northern Tanzania.
Autorzy:: Kahabuka MS; College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia. .; Kibong'oto National Infectious Diseases Hospital, Kilimanjaro, Tanzania. .
Woldeamanuel Y; College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.
Mbelele PM; Kibong'oto National Infectious Diseases Hospital, Kilimanjaro, Tanzania.
Mpolya EA; Department of Global Health and Biomedical Sciences, School of Life Sciences and Bioengineering, Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania.; Institute for Health Metrics and Evaluation, Population Health Building/Hans Rosling Center, University of Washington, 3980 15th Avenue, 98195, Seattle, WA, USA.
Mpagama SG; Kibong'oto National Infectious Diseases Hospital, Kilimanjaro, Tanzania.; Department of Global Health and Biomedical Sciences, School of Life Sciences and Bioengineering, Nelson Mandela African Institution of Science and Technology, Arusha, Tanzania.
Kessy JP; Mawenzi Regional Referral Hospital, Kilimanjaro, Tanzania.
Manyazewal T; College of Health Sciences, Center for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Apr 11; Vol. 24 (1), pp. 390. Date of Electronic Publication: 2024 Apr 11.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*
Acquired Immunodeficiency Syndrome*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Female ; Adult ; Male ; Retrospective Studies ; Antiretroviral Therapy, Highly Active ; Tanzania/epidemiology ; Viral Load

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: Predictors of antiretroviral treatment failure to the first line therapy: a cross-sectional study among Iranian HIV-positive adults.
Autorzy:: Hashempour A; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Khodadad N; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Ziaei R; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Rezaei B; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Ghasabi F; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.
Falahi S; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran.; Zoonotic Diseases Research Center, Ilam University of Medical Sciences, Ilam, Iran.
Kenarkouhi A; Department of Microbiology, Faculty of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Davarpanah MA; HIV/AIDS Research Center, Institute of Health, Shiraz University of Medical Sciences, Shiraz, Iran. .; Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Mar 28; Vol. 24 (1), pp. 358. Date of Electronic Publication: 2024 Mar 28.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*
Anti-HIV Agents*
Adult ; Humans ; Iran ; Cross-Sectional Studies ; Anti-Retroviral Agents/therapeutic use ; Anti-Retroviral Agents/pharmacology ; Treatment Failure ; Viral Load ; CD4 Lymphocyte Count ; Antiretroviral Therapy, Highly Active

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Does HIV index testing bring patients into treatment at earlier stages of HIV disease? Results from a retrospective study in Ukraine.
Autorzy:: Secor AM; Department of Global Health, University of Washington, Hans Rosling Center, 3980 15th Ave NE, 98105, Seattle, WA, USA. .
Ihnatiuk A; International Training and Education Center for Health (I-TECH), Kyiv, Ukraine.
Shapoval A; International Training and Education Center for Health (I-TECH), Kyiv, Ukraine.
McDowell M; International Training and Education Center for Health (I-TECH), Seattle, WA, USA.
Hetman L; Public Health Center (PHC) of the Ministry of Health (MoH) of Ukraine, Kyiv, Ukraine.
Wagner AD; Department of Global Health, University of Washington, Hans Rosling Center, 3980 15th Ave NE, 98105, Seattle, WA, USA.
Pintye J; Department of Global Health, University of Washington, Hans Rosling Center, 3980 15th Ave NE, 98105, Seattle, WA, USA.
Beima-Sofie K; Department of Global Health, University of Washington, Hans Rosling Center, 3980 15th Ave NE, 98105, Seattle, WA, USA.
Golden MR; Department of Medicine, University of Washington, Seattle, WA, USA.; HIV/STD Program, Public Health-Seattle & King County, Seattle, WA, USA.
Puttkammer N; Department of Global Health, University of Washington, Hans Rosling Center, 3980 15th Ave NE, 98105, Seattle, WA, USA.; International Training and Education Center for Health (I-TECH), Seattle, WA, USA.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Mar 18; Vol. 24 (1), pp. 328. Date of Electronic Publication: 2024 Mar 18.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/diagnosis
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Adult ; Humans ; Retrospective Studies ; Ukraine/epidemiology ; Anti-Retroviral Agents/therapeutic use ; HIV Testing

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: Mechanism of action, resistance, interaction, pharmacokinetics, pharmacodynamics, and safety of fostemsavir.
Autorzy:: Heidary M; Department of Laboratory Sciences, School of Paramedical Sciences, Sabzevar University of Medical Sciences, Sabzevar, Iran.; Cellular and Molecular Research Center, Sabzevar University of Medical Sciences, Sabzevar, Iran.
Shariati S; Toxicology Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.; Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Nourigheimasi S; Faculty of Medicine, Arak University of Medical Science, Arak, Iran.
Khorami M; Department of Obstetrics and Gynecology, School of Medicine, Ilam University of Medical Sciences, Ilam, Iran.
Moradi M; Department of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Motahar M; Department of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Bahrami P; Student Research Committee, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Akrami S; Department of Microbiology, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran. .; Students' Scientific Research Center (SSRC), Tehran University of Medical Sciences, Tehran, Iran. .; Department of Microbiology, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran. .
Kaviar VH; Clinical Microbiology Research Center, Ilam University of Medical Sciences, Ilam, Iran. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Feb 23; Vol. 24 (1), pp. 250. Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:: Review; Journal Article
MeSH Terms:: HIV Infections*/drug therapy
HIV-1*
Anti-HIV Agents*/adverse effects
Organophosphates*
Piperazines*
United States ; Humans ; Anti-Retroviral Agents/therapeutic use ; Drug Combinations

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 7.

Tytuł:: Mortality and associated factors among people living with HIV admitted at a tertiary-care hospital in Uganda: a cross-sectional study.
Autorzy:: Owachi D; Kiruddu National Referral Hospital, Kampala, P.O. BOX 6588, Uganda. .
Akatukunda P; Makerere University Joint AIDS Program, Kampala, Uganda.
Nanyanzi DS; Makerere University Joint AIDS Program, Kampala, Uganda.
Katwesigye R; Makerere University Joint AIDS Program, Kampala, Uganda.
Wanyina S; Makerere University Joint AIDS Program, Kampala, Uganda.
Muddu M; Makerere University Joint AIDS Program, Kampala, Uganda.
Kawuma S; Makerere University Joint AIDS Program, Kampala, Uganda.
Kalema N; Infectious Diseases Institute, Kampala, Uganda.
Kabugo C; Kiruddu National Referral Hospital, Kampala, P.O. BOX 6588, Uganda.
Semitala FC; Makerere University Joint AIDS Program, Kampala, Uganda.; Department of Medicine, Makerere University, Kampala, Uganda.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Feb 22; Vol. 24 (1), pp. 239. Date of Electronic Publication: 2024 Feb 22.
Typ publikacji:: Journal Article
MeSH Terms:: Coinfection*/drug therapy
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Liver Diseases*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Female ; Adult ; Male ; Cross-Sectional Studies ; Uganda/epidemiology ; Tertiary Care Centers ; Hospitalization ; CD4 Lymphocyte Count

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 8.

Tytuł:: Incidence of low-level viremia and its impact on virologic failure among people living with HIV who started an integrase strand transfer inhibitors: a longitudinal cohort study.
Autorzy:: Lao X; Department of Infectious Disease, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
Zhang H; WHO Collaborating Centre for Comprehensive Management of HIV Treatment and Care, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
Deng M; Clinical Center for HIV/AIDS, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
Li Q; Department of Infectious Disease, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
Xiao Q; Department of Infectious Disease, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
He L; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Ma L; State Key Laboratory of Infectious Disease Prevention and Control, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, 102206, China.
Song A; Department of Gastroenterology, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
Liang X; Department of Infectious Disease, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
Yu F; Department of Infectious Disease, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
Zhao H; Clinical Center for HIV/AIDS, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China.
Zhang F; Department of Infectious Disease, Beijing Ditan Hospital Capital Medical University, Beijing, 100015, China. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Jan 02; Vol. 24 (1), pp. 8. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Anti-HIV Agents*/pharmacology
Humans ; Longitudinal Studies ; Incidence ; Viremia/drug therapy ; Treatment Failure ; Cohort Studies ; Viral Load ; Integrase Inhibitors ; Integrases/pharmacology ; Integrases/therapeutic use

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 9.

Tytuł:: Prevalence of acquired and transmitted HIV drug resistance in Iran: a systematic review and meta-analysis.
Autorzy:: Mirzaei H; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, 7616911320, Iran.
Eybpoosh S; Department of Epidemiology and Biostatistics, Research Centre for Emerging and Reemerging Infectious Diseases, Pasteur Institute of Iran, Tehran, Iran.
Mehrabi F; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, 7616911320, Iran.
Shojaei MR; Department of Microbiology and Virology, Kerman University of Medical Science, Kerman, Iran.
Mirzazadeh A; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, 7616911320, Iran.; Department of Epidemiology and Biostatistics, Institute for Global Health Sciences, University of California, San Francisco, USA.
Khezri M; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, 7616911320, Iran.; Department of Epidemiology, New York University School of Global Public Health, New York, NY, USA.
Nasiri N; School of Health, Jiroft University of Medical Sciences, Jiroft, Iran.
Sharifi H; HIV/STI Surveillance Research Center, and WHO Collaborating Center for HIV Surveillance, Institute for Futures Studies in Health, Kerman University of Medical Sciences, Kerman, 7616911320, Iran. .; Affiliate, Institute for Global Health Sciences, University of California San Francisco, San Francisco, CA, USA. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Jan 02; Vol. 24 (1), pp. 29. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:: Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:: HIV-1*
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Anti-HIV Agents*/therapeutic use
Anti-HIV Agents*/pharmacology
Humans ; Iran/epidemiology ; Reverse Transcriptase Inhibitors/therapeutic use ; Prevalence ; Drug Resistance, Viral ; Mutation

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 10.

Tytuł:: Factors associated with an unsuppressed viral load among HIV-positive individuals attending STI services in South Africa, 2019.
Autorzy:: Mapiye M; Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa. .; South African Field Epidemiology Training ProgrammeProgramme, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa. .
Ravhuhali K; South African Field Epidemiology Training ProgrammeProgramme, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.
de Voux A; South African Field Epidemiology Training ProgrammeProgramme, National Institute for Communicable Diseases, National Health Laboratory Service, Johannesburg, South Africa.; Division of Epidemiology and Biostatistics, School of Public Health, University of Cape Town, Cape Town, South Africa.
Kufa T; Faculty of Health Sciences, School of Public Health, University of the Witwatersrand, Johannesburg, South Africa.; Centre for HIV/STI, National Institute for Communicable Disease (NICD), Modderfontein, Johannesburg, South Africa.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2024 Jan 30; Vol. 24 (1), pp. 148. Date of Electronic Publication: 2024 Jan 30.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
HIV Infections*/epidemiology
Sexually Transmitted Diseases*/epidemiology
Anti-HIV Agents*/therapeutic use
Humans ; Adult ; South Africa/epidemiology ; Anti-Retroviral Agents/therapeutic use ; Viral Load ; Cross-Sectional Studies

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 11.

Tytuł:: Associations of inter-annual rainfall decreases with subsequent HIV outcomes for persons with HIV on antiretroviral therapy in Southern Africa: a collaborative analysis of cohort studies.
Autorzy:: Trickey A; Population Health Sciences, University of Bristol, Bristol, UK. .
Johnson LF; Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Fung F; Department of Civil Engineering, University of Bristol, Bristol, UK.; UK Meteorological Office, Exeter, UK.
Bonifacio R; Climate and Earth Observation Unit, Research Assessment and Monitoring Division, World Food Programme HQ, Rome, Italy.
Iwuji C; Africa Health Research Institute, KwaZulu-Natal, South Africa.; Department of Global Health Infection, Brighton and Sussex Medical School, University of Sussex, Brighton, UK.
Biraro S; ICAP at Columbia University, Nakasero, Kampala, Uganda.
Bosomprah S; Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.; Department of Biostatistics, School of Public Health, University of Ghana, Legon, Accra, Ghana.
Chirimuta L; Newlands Clinic, Harare, Zimbabwe.
Euvrard J; Centre for Infectious Disease Epidemiology and Research, School of Public Health and Family Medicine, University of Cape Town, Cape Town, South Africa.
Fatti G; Kheth'Impilo AIDS Free Living, Cape Town, South Africa.; Division of Epidemiology and Biostatistics, Department of Global Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Cape Town, South Africa.
Fox MP; Health Economics and Epidemiology Research Office, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; Department of Global Health and Department of Epidemiology, Boston University School of Public Health, Boston, MA, USA.
Von Groote P; Institute of Social and Preventive Medicine, University of Bern, Bern, Switzerland.
Gumulira J; Lighthouse Trust, Mzimba, Malawi.
Howard G; Department of Civil Engineering and Cabot Institute of the Environment, University of Bristol, Bristol, UK.
Jennings L; Desmond Tutu Health Foundation, Institute of Infectious Diseases and Molecular Medicine, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Kiragga A; Research Division, African Population and Health Research Center, Nairobi, Kenya.
Muula G; Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
Tanser F; Centre for Epidemic Response and Innovation, School of Data Science and Computational Thinking, Stellenbosch University, Stellenbosch, South Africa.; School of Nursing and Public Health, University of KwaZulu-Natal, Durban, South Africa.
Wagener T; Institute of Environmental Science and Geography, University of Potsdam, Potsdam, Germany.
Low A; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.
Vickerman P; Population Health Sciences, University of Bristol, Bristol, UK.; NIHR Health Protection Research Unit in Behavioural Science and Evaluation at University of Bristol, Bristol, UK.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 Dec 19; Vol. 23 (1), pp. 889. Date of Electronic Publication: 2023 Dec 19.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Infections*/complications
Anti-HIV Agents*/therapeutic use
Adult ; Humans ; Female ; Male ; CD4 Lymphocyte Count ; Africa, Southern/epidemiology ; Cohort Studies ; South Africa

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 12.

Tytuł:: Evaluation of multiple data sources for predicting increased need for HIV prevention among cisgender women: understanding missed opportunities for Pre-exposure Prophylaxis (PrEP).
Autorzy:: Johnson AK; Reasearch Associate Professor Center for Gender, Sexuality, and HIV Prevention, The Potocsnak Family Division of Adolescent and Young Adult Medicine, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. .
Devlin S; Research Coordinator, University of Chicago, Chicago, IL, USA.
Haider S; Division of Family Planning, Rush University Medical Center (RUMC), Chicago, IL, USA.
Oehler C; Clinical Assistant Professor Allegheny Health Network, Drexel University School of Medicine, Pennsylvania, USA.
Rivera J; Social and Behavioral Research Manager, Howard Brown Health, Chicago, USA.
Alvarez I; Clinical Research Coordinator, Division of Family Planning, Rush University Medical Center (RUMC), Chicago, IL, USA.
Ridgway J; Biological Sciences Division, University of Chicago, Chicago, IL, USA.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 Nov 09; Vol. 23 (1), pp. 781. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/epidemiology
HIV Infections*/prevention & control
Pre-Exposure Prophylaxis*
Sexual and Gender Minorities*
Anti-HIV Agents*/therapeutic use
Male ; Humans ; Female ; Homosexuality, Male ; Information Sources

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 13.

Tytuł:: Transmitted drug resistance and subtype patterns of viruses from reported new HIV diagnoses in Germany, 2017-2020.
Autorzy:: Fiebig U; Unit 18 'HIV and other Retroviruses, Sexually transmitted bacterial Pathogens (STI) and HIV', Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Altmann B; Unit 18 'HIV and other Retroviruses', Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Hauser A; Unit 18 'HIV and other Retroviruses', Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Koppe U; Unit 34 'HIV/AIDS, STI and Blood-borne Infections', Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Hanke K; Unit 18 'HIV and other Retroviruses, Sexually transmitted bacterial Pathogens (STI) and HIV', Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany.
Gunsenheimer-Bartmeyer B; Unit 34 'HIV/AIDS, STI and Blood-borne Infections', Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Bremer V; Unit 34 'HIV/AIDS, STI and Blood-borne Infections', Department of Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany.
Baumgarten A; Center for Infectiology Berlin-Prenzlauer Berg, Nordufer 20, 13353, Berlin, Germany.
Bannert N; Unit 18 'HIV and other Retroviruses, Sexually transmitted bacterial Pathogens (STI) and HIV', Department of Infectious Diseases, Robert Koch Institute, Berlin, Germany. .; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 Oct 10; Vol. 23 (1), pp. 673. Date of Electronic Publication: 2023 Oct 10.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/diagnosis
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Sexual and Gender Minorities*
Anti-HIV Agents*/pharmacology
Anti-HIV Agents*/therapeutic use
Viruses*
Male ; Humans ; Homosexuality, Male ; Drug Resistance, Viral/genetics ; Mutation ; DNA-Directed RNA Polymerases/genetics ; Reverse Transcriptase Inhibitors/pharmacology ; Reverse Transcriptase Inhibitors/therapeutic use ; Genotype

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 14.

Tytuł:: The burden of anemia among Chinese HIV-infected patients following the initiation of antiretroviral therapy in the treat-all era: a nationwide cohort study.
Autorzy:: Wei L; Division of Treatment and Care, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Road, Changping District, Beijing, China.
Zhao Y; Division of Treatment and Care, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Road, Changping District, Beijing, China. .
Gan X; Division of Treatment and Care, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Road, Changping District, Beijing, China.
Zhao D; Division of Treatment and Care, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Road, Changping District, Beijing, China.
Wu Y; Division of Treatment and Care, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Road, Changping District, Beijing, China.
Dou Z; Division of Treatment and Care, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Road, Changping District, Beijing, China.
Ma Y; Division of Treatment and Care, National Center for AIDS/STD Control and Prevention, Chinese Center for Disease Control and Prevention, No. 155, Changbai Road, Changping District, Beijing, China.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 Oct 19; Vol. 23 (1), pp. 704. Date of Electronic Publication: 2023 Oct 19.
Typ publikacji:: Journal Article
MeSH Terms:: Anemia*/drug therapy
Anemia*/epidemiology
Anemia*/etiology
Anemia*/mortality
Anti-HIV Agents*/therapeutic use
HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Infections*/mortality
Humans ; Cohort Studies ; East Asian People ; Proportional Hazards Models

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 15.

Tytuł:: Prophylaxis by doravirine-lamivudine-tenofovir disoproxil fumarate or elvitegravir-cobicistat-emtricitabine-tenofovir alafenamide after sexual exposure to HIV.
Autorzy:: Devred I; Hôpital Saint-Antoine, Assistance Publique Des Hôpitaux de Paris, Service Des Maladies Infectieuses Et Tropicales, 184 Rue du Faubourg Saint-Antoine, F75571, Cedex 12, Paris, France. .
Kayembe K; Hôpital Saint-Antoine, Assistance Publique Des Hôpitaux de Paris, Service Des Maladies Infectieuses Et Tropicales, 184 Rue du Faubourg Saint-Antoine, F75571, Cedex 12, Paris, France. .
Valin N; Hôpital Saint-Antoine, Assistance Publique Des Hôpitaux de Paris, Service Des Maladies Infectieuses Et Tropicales, 184 Rue du Faubourg Saint-Antoine, F75571, Cedex 12, Paris, France.
Rougier H; Hôpital Saint-Antoine, Assistance Publique Des Hôpitaux de Paris, Service Des Maladies Infectieuses Et Tropicales, 184 Rue du Faubourg Saint-Antoine, F75571, Cedex 12, Paris, France.; Institut de Médecine et d'Epidémiologie Appliquée, Paris, 75018, France.
Shinga BW; Hôpital Saint-Antoine, Assistance Publique Des Hôpitaux de Paris, Service Des Maladies Infectieuses Et Tropicales, 184 Rue du Faubourg Saint-Antoine, F75571, Cedex 12, Paris, France.
Lambert-Niclot S; Sorbonne Université, 91-105 Boulevard de L'Hôpital, 75013, Paris, France.; Hôpital Saint-Antoine, Assistance Publique Des Hôpitaux de Paris, Service de Virologie, 184 Rue du Faubourg Saint-Antoine, F75571, Cedex 12, Paris, France.
Chiarabini T; Hôpital Saint-Antoine, Assistance Publique Des Hôpitaux de Paris, Service Des Maladies Infectieuses Et Tropicales, 184 Rue du Faubourg Saint-Antoine, F75571, Cedex 12, Paris, France.
Meyohas MC; Hôpital Saint-Antoine, Assistance Publique Des Hôpitaux de Paris, Service Des Maladies Infectieuses Et Tropicales, 184 Rue du Faubourg Saint-Antoine, F75571, Cedex 12, Paris, France.; Sorbonne Université, 91-105 Boulevard de L'Hôpital, 75013, Paris, France.
Lacombe K; Hôpital Saint-Antoine, Assistance Publique Des Hôpitaux de Paris, Service Des Maladies Infectieuses Et Tropicales, 184 Rue du Faubourg Saint-Antoine, F75571, Cedex 12, Paris, France.; Sorbonne Université, 91-105 Boulevard de L'Hôpital, 75013, Paris, France.; Institut Pierre Louis de Santé Publique, Inserm UMR-S1136, F75571, Cedex 12, Paris, France.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 Sep 04; Vol. 23 (1), pp. 578. Date of Electronic Publication: 2023 Sep 04.
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: Anti-HIV Agents*/therapeutic use
Drug-Related Side Effects and Adverse Reactions*
HIV Infections*/drug therapy
HIV Infections*/prevention & control
Adult ; Humans ; Lamivudine/therapeutic use ; Tenofovir/therapeutic use ; Fumarates ; Emtricitabine ; Cobicistat

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 16.

Tytuł:: The impact of integrase inhibitors on steatosis and fibrosis biomarkers in persons with HIV naïve to antiretroviral therapy.
Autorzy:: Fernandes SR; Faculdade de Medicina, Universidade do Porto, Porto, Portugal. .
Leite AR; Serviço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário São João, Faculdade de Medicina, Universidade do Porto, Porto, Portugal.
Lino R; Departamento de Doenças Infeciosas do Centro Hospitalar Universitário São João, Porto, Portugal.
Guimarães AR; Departamento de Doenças Infeciosas do Centro Hospitalar Universitário São João, Porto, Portugal.
Pineiro C; Departamento de Doenças Infeciosas do Centro Hospitalar Universitário São João, Porto, Portugal.
Serrão R; Departamento de Doenças Infeciosas do Centro Hospitalar Universitário São João, Porto, Portugal.
Freitas P; Serviço de Endocrinologia, Diabetes e Metabolismo do Centro Hospitalar Universitário São João, Faculdade de Medicina, Investigação e Inovação em Saúde (i3s), Universidade do Porto, Porto, Portugal.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 Aug 24; Vol. 23 (1), pp. 553. Date of Electronic Publication: 2023 Aug 24.
Typ publikacji:: Journal Article
MeSH Terms:: Non-alcoholic Fatty Liver Disease*
HIV Infections*/complications
HIV Infections*/drug therapy
Anti-HIV Agents*
Humans ; Male ; Adult ; Female ; Integrase Inhibitors ; Retrospective Studies ; Liver Cirrhosis/etiology ; Biomarkers

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 17.

Tytuł:: Diabetes in a hospital cohort of persons living with HIV: a descriptive and comparative study in French Guiana.
Autorzy:: Nacher M; CIC INSERM 1424, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana. .; DFR Santé, Université de Guyane, Cayenne, 97300, French Guiana. .; COREVIH Guyane, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana. .
Rabier S; COREVIH Guyane, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana.
Lucarelli A; COREVIH Guyane, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana.
Hureau L; COREVIH Guyane, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana.
Adenis A; CIC INSERM 1424, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana.; DFR Santé, Université de Guyane, Cayenne, 97300, French Guiana.; COREVIH Guyane, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana.
Hafsi N; Service d'endocrinologie diabétologie, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana.
Sabbah N; Service d'endocrinologie diabétologie, Centre Hospitalier de Cayenne, Cayenne, 97300, French Guiana.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 Jul 13; Vol. 23 (1), pp. 470. Date of Electronic Publication: 2023 Jul 13.
Typ publikacji:: Journal Article
MeSH Terms:: HIV Infections*/complications
HIV Infections*/drug therapy
HIV Infections*/epidemiology
Diabetes Mellitus, Type 2*/complications
Diabetes Mellitus, Type 2*/epidemiology
Diabetes Mellitus, Type 2*/drug therapy
HIV Seropositivity*/drug therapy
Anti-HIV Agents*/therapeutic use
Male ; Humans ; Female ; French Guiana/epidemiology ; CD4 Lymphocyte Count ; Viral Load ; Hospitals

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 18.

Tytuł:: The effects of revised peer-counselor support on the PMTCT cascade of care: results from a cluster-randomized trial in Kenya (the EMMA study).
Autorzy:: Larson BA; Department of Global Health, Boston University School of Public Health, 801 Massachusetts Avenue, Boston, MA, 02118, USA. .
Tsikhutsu I; Kenya Medical Research Institute, Kericho, Kenya/U.S. Army Medical Research Directorate-Africa, Nairobi, Kenya.; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.; HJF Medical Research International, Kericho, Kenya.
Bii M; Kenya Medical Research Institute, Kericho, Kenya/U.S. Army Medical Research Directorate-Africa, Nairobi, Kenya.; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.; HJF Medical Research International, Kericho, Kenya.
Halim N; Department of Global Health, Boston University School of Public Health, 801 Massachusetts Avenue, Boston, MA, 02118, USA.
Agaba P; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA.
Sugut W; Kenya Medical Research Institute, Kericho, Kenya/U.S. Army Medical Research Directorate-Africa, Nairobi, Kenya.; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.; HJF Medical Research International, Kericho, Kenya.
Muli J; Kenya Medical Research Institute, Kericho, Kenya/U.S. Army Medical Research Directorate-Africa, Nairobi, Kenya.; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.; HJF Medical Research International, Kericho, Kenya.
Sawe F; Kenya Medical Research Institute, Kericho, Kenya/U.S. Army Medical Research Directorate-Africa, Nairobi, Kenya.; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, Maryland, USA.; HJF Medical Research International, Kericho, Kenya.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 Apr 25; Vol. 23 (1), pp. 257. Date of Electronic Publication: 2023 Apr 25.
Typ publikacji:: Randomized Controlled Trial; Journal Article
MeSH Terms:: Anti-HIV Agents*/therapeutic use
Counselors*
HIV Infections*/diagnosis
HIV Infections*/drug therapy
Pregnancy Complications, Infectious*/drug therapy
Infant ; Child ; Female ; Pregnancy ; Humans ; Kenya ; Infectious Disease Transmission, Vertical/prevention & control

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 19.

Tytuł:: Lipids and transaminase elevations in ARV-experienced PLWH switching to a doravirine-based regimen from rilpivirine or other regimens.
Autorzy:: Maggi P; Infectious Diseases Unit, AORN Sant'Anna e San Sebastiano, Caserta, Italy.
Ricci ED; Fondazione ASIA Onlus, Via Garibaldi, 13, Buccinasco, 20090, MI, Italy. .
Cicalini S; National Institute for Infectious Diseases Lazzaro Spallanzani Institute for Hospitalization and Care Scientific, Roma, Lazio, Italy.
Pellicanò GF; Unit of Infectious Diseases, Department of Human Pathology of the Adult and the Developmental Age 'G. Barresi', University of Messina, Messina, Italy.
Celesia BM; Unit of Infectious Diseases, Garibaldi Hospital, Catania, Italy.
Vichi F; Unit of Infectious Diseases, USLCENTRO FIRENZE, Santa Maria Annunziata Hospital, Florence, Italy.
Cascio A; Unit of Infectious Diseases, Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.
Sarchi E; Infectious Diseases Unit, S.Antonio e Biagio e Cesare Arrigo Hospital, Alessandria, Italy.
Orofino G; Division I of Infectious and Tropical Diseases, ASL Città di Torino, Torino, Italy.
Squillace N; Infectious Disease Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Madeddu G; Unit of Infectious Diseases, Department of Medicine, Surgery and Pharmacy, University of Sassari, Sassari, Italy.
De Socio GV; Unit of Infectious Diseases, Santa Maria Hospital, Perugia, Italy.
Bargiacchi O; Unit of Infectious Diseases, Ospedale Maggiore della Carità, Novara, Italy.
Molteni C; Unit of Infectious Diseases, A. Manzoni Hospital, Lecco, Italy.
Masiello A; Infectious Diseases Unit, AORN Sant'Anna e San Sebastiano, Caserta, Italy.
Saracino A; Department of Biomedical Sciences and Human Oncology, Clinic of Infectious Diseases, University of Bari Aldo Moro, Bari, Italy.
Menzaghi B; Unit of Infectious Diseases, ASST della Valle Olona - Busto Arsizio (VA), Busto Arsizio VA, Italy.
Falasca K; Clinic of Infectious Diseases, Department of Medicine and Science of Aging, G. D'Annunzio University, Chieti-Pescara, Chieti, Italy.
Taramasso L; Infectious Diseases, San Martino Hospital Genoa, University of Genoa, Genoa, Italy.
Di Biagio A; Infectious Diseases, San Martino Hospital Genoa, University of Genoa, Genoa, Italy.
Bonfanti P; Infectious Disease Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza - University of Milano-Bicocca, Monza, Italy.; Pokaż więcej
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 Apr 14; Vol. 23 (1), pp. 227. Date of Electronic Publication: 2023 Apr 14.
Typ publikacji:: Journal Article
MeSH Terms:: Anti-HIV Agents*/therapeutic use
HIV Infections*/drug therapy
Humans ; Rilpivirine/therapeutic use ; Reverse Transcriptase Inhibitors/therapeutic use ; Lipids

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 20.

Tytuł:: Decentralization of viral load testing to improve HIV care and treatment cascade in rural Tanzania: observational study from the Kilombero and Ulanga Antiretroviral Cohort.
Autorzy:: Mnzava D; Ifakara Health Institute, Ifakara Branch, Ifakara, United Republic of Tanzania.
Okuma J; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Ndege R; Ifakara Health Institute, Ifakara Branch, Ifakara, United Republic of Tanzania.; St. Francis Referral Hospital, Ifakara, United Republic of Tanzania.
Kimera N; Ifakara Health Institute, Ifakara Branch, Ifakara, United Republic of Tanzania.
Ntamatungiro A; Ifakara Health Institute, Ifakara Branch, Ifakara, United Republic of Tanzania.
Nyuri A; Ifakara Health Institute, Ifakara Branch, Ifakara, United Republic of Tanzania.
Byakuzana T; Ifakara Health Institute, Ifakara Branch, Ifakara, United Republic of Tanzania.
Abilahi F; Ifakara Health Institute, Ifakara Branch, Ifakara, United Republic of Tanzania.
Mayeka P; USAID Boresha Afya, Morogoro, United Republic of Tanzania.
Temba E; USAID Boresha Afya, Morogoro, United Republic of Tanzania.
Fanuel T; USAID Boresha Afya, Morogoro, United Republic of Tanzania.
Glass TR; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Klimkait T; Department of Biomedicine, Molecular Virology, University of Basel, Basel, Switzerland.
Vanobberghen F; Swiss Tropical and Public Health Institute, Basel, Switzerland.; University of Basel, Basel, Switzerland.
Weisser M; Ifakara Health Institute, Ifakara Branch, Ifakara, United Republic of Tanzania. .; Swiss Tropical and Public Health Institute, Basel, Switzerland. .; University of Basel, Basel, Switzerland. .; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Basel, CH, Basel, Switzerland. .; Pokaż więcej
Corporate Authors:: KIULARCO Study Group
Źródło:: BMC infectious diseases [BMC Infect Dis] 2023 Apr 07; Vol. 23 (1), pp. 222. Date of Electronic Publication: 2023 Apr 07.
Typ publikacji:: Observational Study; Journal Article
MeSH Terms:: HIV Infections*/drug therapy
Anti-HIV Agents*/therapeutic use
Humans ; Prospective Studies ; Viral Load/methods ; Tanzania/epidemiology ; Anti-Retroviral Agents/therapeutic use ; Politics

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Informacja

Wyszukujesz frazę ""Anti-HIV Agents"" wg kryterium: Temat

Źródło danych

Ogranicz do:

Ogranicz do bazy

Typ dokumentu

Temat

Wydawca

Język